These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Therapeutic trial of multiple sclerosis using immunosuppressive agents]. Cendrowski W. Neurol Neurochir Pol; 1969; 3(4):475-9. PubMed ID: 4309196 [No Abstract] [Full Text] [Related]
3. [Cyclophosphamide in the therapy of multiple sclerosis]. Salvatores U, Majeron M, Mascetti A. Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb 29; 96(1):163-84. PubMed ID: 4337775 [No Abstract] [Full Text] [Related]
4. Immunosuppressive drugs in multiple sclerosis: pro and con. Ellison GW, Myers LW. Neurology; 1980 Jul 29; 30(7 Pt 2):28-32. PubMed ID: 6248818 [No Abstract] [Full Text] [Related]
5. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis. Hauser SL, Fosburg M, Kevy S, Weiner HL. Prog Clin Biol Res; 1982 Jul 29; 106():239-54. PubMed ID: 6184727 [Abstract] [Full Text] [Related]
6. [Critic study of multiple sclerosis treatment by chlorambucil and intraspinal corticotherapy. Apropos of 100 cases followed up from 2 to 9 years]. Sigwald J, Mazalton A, Raymondeaud C, Piot C, Jacquillat C. Rev Neurol (Paris); 1973 Jan 29; 128(1):72-7. PubMed ID: 4367744 [No Abstract] [Full Text] [Related]
7. Combined therapeutic trial in multiple sclerosis: hydrocortisone hemisuccinate with cyclophosphamide or cytosine arabinoside. Cendrowski W. Acta Neurol Belg; 1973 Jan 29; 73(4):209-19. PubMed ID: 4770124 [No Abstract] [Full Text] [Related]
8. [Acute leukemia secondary to the treatment of multiple sclerosis with chlorambucil]. Aymard JP, Witz F, Conroy T, Lederlin P, Humbert JC, Barroche G, Streiff F. Rev Neurol (Paris); 1985 Jan 29; 141(2):152-4. PubMed ID: 3858929 [Abstract] [Full Text] [Related]
12. [Immunodepressors in ophthalmology]. Bonnet M. Annee Ther Clin Ophtalmol; 1971 Jan 29; 22():117-55. PubMed ID: 4356770 [No Abstract] [Full Text] [Related]
13. Immunosuppressive therapy in neurological diseases. Cendrowski W, Riekkinen PJ, Rinne UK. Ann Clin Res; 1974 Dec 29; 6(6):323-9. PubMed ID: 4375431 [No Abstract] [Full Text] [Related]
14. The peculiar difficulties of therapeutic trials for multiple sclerosis. Myers LW, Ellison GW. Neurol Clin; 1990 Feb 29; 8(1):119-41. PubMed ID: 1690838 [Abstract] [Full Text] [Related]
15. [Critical opinions on the treatment of multiple sclerosis with immunosuppressive agents]. Skłodowski P. Neurol Neurochir Pol; 1993 Feb 29; 27(6):877-83. PubMed ID: 8164783 [Abstract] [Full Text] [Related]
16. [Immunosuppressive therapy of multiple sclerosis using cyclophosphamide with few side effects]. Kornhuber HH, Mauch E. Dtsch Med Wochenschr; 1986 Nov 14; 111(46):1778. PubMed ID: 3780443 [No Abstract] [Full Text] [Related]
17. Immunosuppressive drugs in rheumatoid arthritis. Currey HL. Mod Trends Rheumatol; 1971 Nov 14; 2():174-98. PubMed ID: 4344785 [No Abstract] [Full Text] [Related]
18. Medications used in the treatment of multiple sclerosis. Schapiro RT. Phys Med Rehabil Clin N Am; 1999 May 14; 10(2):437-46, ix. PubMed ID: 10370939 [Abstract] [Full Text] [Related]
19. [Our experience of chronic rheumatic polyarthritis therapy with immunosuppressive agents. Apropos of 41 cases]. Arlet J, Mole J, Debrock J. Rev Rhum Mal Osteoartic; 1971 Dec 14; 38(12):771-4. PubMed ID: 5152709 [No Abstract] [Full Text] [Related]
20. [Immunosuppressive medication in multiple sclerosis]. García Merino JA. Rev Neurol; 1971 Dec 14; 35(12):1154-8. PubMed ID: 12497298 [Abstract] [Full Text] [Related] Page: [Next] [New Search]